122 related articles for article (PubMed ID: 2996294)
1. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
[No Abstract] [Full Text] [Related]
2. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
[No Abstract] [Full Text] [Related]
3. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
[TBL] [Abstract][Full Text] [Related]
4. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
[No Abstract] [Full Text] [Related]
5. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
[TBL] [Abstract][Full Text] [Related]
6. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
[TBL] [Abstract][Full Text] [Related]
7. 2-substituted tetralin derivatives as conformationally restricted butyrophenone analogs.
Chan CC; Farmer PS; McKenzie G; Robertson H
Pharmazie; 1987 Jun; 42(6):369-71. PubMed ID: 2890175
[TBL] [Abstract][Full Text] [Related]
8. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
[TBL] [Abstract][Full Text] [Related]
9. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
[TBL] [Abstract][Full Text] [Related]
10. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
Arvidsson LE; Karlén A; Norinder U; Kenne L; Sundell S; Hacksell U
J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
[TBL] [Abstract][Full Text] [Related]
11. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
[TBL] [Abstract][Full Text] [Related]
12. Compounds with selectivity for dopamine autoreceptors: effects on prolactin secretion in male and female rats.
Eriksson E; Carlsson M; Clark D; Nilsson C; Svensson K
Clin Neuropharmacol; 1986; 9 Suppl 4():226-8. PubMed ID: 3567942
[No Abstract] [Full Text] [Related]
13. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
Wikström H; Elebring T; Hallnemo G; Andersson B; Svensson K; Carlsson A; Rollema H
J Med Chem; 1988 Jun; 31(6):1080-4. PubMed ID: 2967374
[TBL] [Abstract][Full Text] [Related]
14. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
[TBL] [Abstract][Full Text] [Related]
15. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
[TBL] [Abstract][Full Text] [Related]
16. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
Middlemiss DN; Fozard JR
Eur J Pharmacol; 1983 May; 90(1):151-3. PubMed ID: 6223827
[No Abstract] [Full Text] [Related]
17. Recent observations on new potential and established antidepressant drugs.
Carlsson A
Pharmacopsychiatria; 1982 Jul; 15(4):116-20. PubMed ID: 6216489
[No Abstract] [Full Text] [Related]
18. Current theories on the mode of action of antidepressant drugs.
Carlsson A
Adv Biochem Psychopharmacol; 1984; 39():213-21. PubMed ID: 6235723
[No Abstract] [Full Text] [Related]
19. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
Svensson K; Johansson AM; Magnusson T; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
[TBL] [Abstract][Full Text] [Related]
20. Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.
Karlén A; Johansson AM; Kenne L; Arvidsson LE; Hacksell U
J Med Chem; 1986 Jun; 29(6):917-24. PubMed ID: 3712382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
